4.6 Article

Naive Human Macrophages Are Refractory to SARS-CoV-2 Infection and Exhibit a Modest Inflammatory Response Early in Infection

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

A common TMPRSS2 variant has a protective effect against severe COVID-19

Alessia David et al.

Summary: A common genetic variant (rs12329760) in the TMPRSS2 gene is associated with a significantly decreased risk of severe COVID-19. Further studies are needed to assess TMPRSS2 expression across different age groups, and TMPRSS2 may serve as a promising drug target in the treatment of COVID-19.

CURRENT RESEARCH IN TRANSLATIONAL MEDICINE (2022)

Article Immunology

Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis

Asma Boumaza et al.

Summary: The study found that monocytes and macrophages from COVID-19 patients can be infected by SARS-CoV-2, leading to secretion of immunoregulatory cytokines and induction of a specific transcriptional program in macrophages. Single-cell analysis in COVID-19 patients revealed lower monocyte counts affecting all subsets, decreased expression of HLA-DR, and increased expression of CD163, regardless of disease severity.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Immunology

Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison

Ioanna-Evdokia Galani et al.

Summary: Andreakos and colleagues conducted a study comparing patients with COVID-19 and influenza, finding that COVID-19 patients exhibited a dysregulated interferon response with diminished and delayed interferon production compared to flu patients. In COVID-19 patients, pro-inflammatory cytokines were produced before interferons and persisted longer, leading to worsened clinical outcomes.

NATURE IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Immune determinants of COVID-19 disease presentation and severity

Petter Brodin

Summary: The severity of COVID-19 varies by sex and age, and is linked to comorbidities. Differences in immune reactions may go some way to explain this.

NATURE MEDICINE (2021)

Article Multidisciplinary Sciences

Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity

Egle Kvedaraite et al.

Summary: This study found that COVID-19 patients experience a redistribution of monocyte subsets towards intermediate monocytes and a general decrease in circulating dendritic cells. Severe disease is associated with the appearance of monocytic myeloid-derived suppressor cell-like cells and a higher frequency of pre-DC2. The phenotypic alterations in mononuclear phagocytes are cell-lineage-specific and linked to the response against SARS-CoV-2 or COVID-19 severity.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Medicine, Research & Experimental

An immune-based biomarker signature is associated with mortality in COVID-19 patients

Michael S. Abers et al.

Summary: Immune and inflammatory responses are important factors contributing to disease severity in COVID-19. This study identified specific immune-based biomarkers associated with mortality in COVID-19 patients, with some biomarkers consistently higher in those who died compared to those who recovered, suggesting their potential for early prediction of disease outcome.

JCI INSIGHT (2021)

Review Immunology

Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned

Varvara A. Ryabkova et al.

Summary: The review suggests that lessons from immunomodulatory therapy of COVID-19 can be applied to severe influenza infection and future outbreaks of severe respiratory viral infections, including the choice of immunomodulatory drugs, patient selection, and timing of therapy.

CLINICAL IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Type I and III interferon responses in SARS-CoV-2 infection

You-Me Kim et al.

Summary: Researchers have reviewed how SARS-CoV-2 manipulates the immune system by inhibiting host IFN responses, leading to delayed and exaggerated inflammation, which contributes to the severity of COVID-19. Further investigations are needed to better understand the mechanisms behind these immune system dysfunctions caused by the virus.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Article Medicine, Research & Experimental

Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19

Suchitra Kamle et al.

Summary: CHI3L1 is induced in elderly individuals and patients with comorbid diseases, playing a significant role in stimulating ACE2 and SPP during SC2 infection, and its levels correlate with COVID-19 severity.

JCI INSIGHT (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation

Lucy G. Thorne et al.

Summary: SARS-CoV-2 infection leads to broad-spectrum immunopathological diseases, exacerbated by inflammatory co-morbidities. Research shows that the virus replicates rapidly in lung epithelial cells and triggers a robust innate immune response, affecting macrophage activation through inflammatory mediators produced during infection. Further exacerbation of the local inflammatory environment occurs when macrophages or epithelial cells are primed with exogenous inflammatory stimuli.

EMBO JOURNAL (2021)

Article Multidisciplinary Sciences

The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells

D. A. Leach et al.

Summary: Antiandrogen treatment reduces TMPRSS2 expression in the lung, decreasing SARS-CoV-2 viral entry and infection, supporting the potential of antiandrogens as a therapeutic approach for COVID-19.

NATURE COMMUNICATIONS (2021)

Article Immunology

Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection

Marc A. Niles et al.

Summary: Research indicates that mDC and macrophages are susceptible to SARS-CoV-2 infection, but do not produce the virus and show minimal changes in activation status upon infection. Infected innate immune cells do not produce pro-inflammatory cytokines, suggesting they are unlikely to be the source of the initial wave of cytokines post-SARS-CoV-2 infection.

FRONTIERS IN IMMUNOLOGY (2021)

Article Medicine, General & Internal

Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19

Salim S. Hayek et al.

Summary: The study found that higher serum OPN levels in COVID-19 patients are associated with increased odds of death and the need for mechanical ventilation, but the association with the need for renal replacement therapy is unclear.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Structure analysis of the receptor binding of 2019-nCoV

Yun Chen et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Daniel Blanco-Melo et al.

Article Biochemistry & Molecular Biology

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients

Pierre Bost et al.

Article Multidisciplinary Sciences

Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury

Yingxia Liu et al.

NATIONAL SCIENCE REVIEW (2020)

Letter Critical Care Medicine

Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2

Yu Zhao et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Immunology

The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?

Zaid Abassi et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Immunology

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Yujun Tang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

The protein expression profile of ACE2 in human tissues

Feria Hikmet et al.

MOLECULAR SYSTEMS BIOLOGY (2020)

Article Multidisciplinary Sciences

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Jerome Hadjadj et al.

SCIENCE (2020)

Article Biochemistry & Molecular Biology

An inflammatory cytokine signature predicts COVID-19 severity and survival

Diane Marie Del Valle et al.

NATURE MEDICINE (2020)

Editorial Material Pharmacology & Pharmacy

Targeting inflammation and cytokine storm in COVID-19

Qianwen Huang et al.

PHARMACOLOGICAL RESEARCH (2020)

Article Biochemistry & Molecular Biology

IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19

Yu Chen et al.

MOLECULAR MEDICINE (2020)

Review Immunology

The trinity of COVID-19: immunity, inflammation and intervention

Matthew Zirui Tay et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Immunology

New fronts emerge in the influenza cytokine storm

Xi-zhi J. Guo et al.

SEMINARS IN IMMUNOPATHOLOGY (2017)

Review Immunology

The cytokine storm of severe influenza and development of immunomodulatory therapy

Qiang Liu et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2016)

Article Multidisciplinary Sciences

Species difference in ANP32A underlies influenza A virus polymerase host restriction

Jason S. Long et al.

NATURE (2016)

Article Immunology

Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny

Martin Guilliams et al.

NATURE REVIEWS IMMUNOLOGY (2014)

Article Immunology

The resolution of inflammation

Christopher D. Buckley et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Review Immunology

Host response to influenza virus: protection versus immunopathology

J. S. M. Peiris et al.

CURRENT OPINION IN IMMUNOLOGY (2010)

Article Biochemistry & Molecular Biology

A new mathematical model for relative quantification in real-time RT-PCR

MW Pfaffl

NUCLEIC ACIDS RESEARCH (2001)